; (5) implementing appropriate safeguards, which may include the use of software or other tools, in gene synthesis equipment to facilitate screening of nucleic acid sequences and, as applicable, customers; (6) maintaining records of customer orders, metadata, and screening system or protocol performance in specified formats, which may include standardized machine-readable and interoperable data formats